Literature DB >> 22823180

Effect of an employer-sponsored health and wellness program on medical cost and utilization.

Hangsheng Liu1, Katherine M Harris, Sarah Weinberger, Seth Serxner, Soeren Mattke, Ellen Exum.   

Abstract

The objective of this study was to examine the impact of PepsiCo's health and wellness program on medical cost and utilization. The authors analyzed health plan and program data of employees and dependents 19-64 years of age, who had 2 years of baseline data (2002 and 2003) and at least 1 year of data from the intervention period (2004 to 2007), resulting in a sample of 55,030 members. Program effects were measured using a difference-in-difference approach based on a multivariate regression model with an individual-level random effect. In its first year, the program was associated with a relative increase in per member per month (PMPM) cost ($66, P<0.01); a relative reduction in PMPM costs of $76 (P<0.01) and $61 (P<0.01) was seen in the second and third year, respectively. Over all 3 years, the program was associated with reduced PMPM costs of $38 (P<0.01), a decrease of 50 emergency room visits per 1000 member years (P<0.01), and a decrease of 16 hospital admissions per 1000 member years (P<0.01). The disease management component reduced PMPM costs by $154 (P<0.01), case management increased PMPM costs by $2795 (P<0.01), but no significant effects were observed for lifestyle management over the 3 intervention years. The implementation of a comprehensive health and wellness program was associated with a cost increase in the first year, followed by a decrease in the following years. These results highlight the importance of taking a long-term perspective when implementing such programs and evaluating their effectiveness.

Mesh:

Year:  2012        PMID: 22823180      PMCID: PMC3883086          DOI: 10.1089/pop.2013.1691

Source DB:  PubMed          Journal:  Popul Health Manag        ISSN: 1942-7891            Impact factor:   2.459


  35 in total

1.  The standardisation of terminology of lower urinary tract function: report from the Standardisation Sub-committee of the International Continence Society.

Authors:  Paul Abrams; Linda Cardozo; Magnus Fall; Derek Griffiths; Peter Rosier; Ulf Ulmsten; Philip van Kerrebroeck; Arne Victor; Alan Wein
Journal:  Neurourol Urodyn       Date:  2002       Impact factor: 2.696

2.  Long-term evaluation of transurethral needle ablation of the prostate (TUNA) for treatment of symptomatic benign prostatic hyperplasia: clinical outcome up to five years from three centers.

Authors:  Alexandre R Zlotta; Xenofon Giannakopoulos; Odd Maehlum; Tonnes Ostrem; Claude C Schulman
Journal:  Eur Urol       Date:  2003-07       Impact factor: 20.096

3.  TURP in the new century: an analytical reappraisal in light of lasers.

Authors:  Assaad El-Hakim
Journal:  Can Urol Assoc J       Date:  2010-10       Impact factor: 1.862

4.  Physicians' awareness and attitudes toward decision aids for patients with cancer.

Authors:  Chantalle Brace; Selina Schmocker; Harden Huang; J Charles Victor; Robin S McLeod; Erin D Kennedy
Journal:  J Clin Oncol       Date:  2010-03-30       Impact factor: 44.544

5.  Long-term follow-up of transurethral microwave thermotherapy.

Authors:  K O Lau; M K Li; K T Foo
Journal:  Urology       Date:  1998-11       Impact factor: 2.649

6.  Update on AUA guideline on the management of benign prostatic hyperplasia.

Authors:  Kevin T McVary; Claus G Roehrborn; Andrew L Avins; Michael J Barry; Reginald C Bruskewitz; Robert F Donnell; Harris E Foster; Chris M Gonzalez; Steven A Kaplan; David F Penson; James C Ulchaker; John T Wei
Journal:  J Urol       Date:  2011-03-21       Impact factor: 7.450

7.  Safety and feasibility of the prostatic urethral lift: a novel, minimally invasive treatment for lower urinary tract symptoms (LUTS) secondary to benign prostatic hyperplasia (BPH).

Authors:  Henry H Woo; Peter T Chin; Thomas A McNicholas; Harcharan S Gill; Mark K Plante; Reginald C Bruskewitz; Claus G Roehrborn
Journal:  BJU Int       Date:  2011-05-06       Impact factor: 5.588

Review 8.  [Transurethral resection for benign prostatic hyperplasia. current developments].

Authors:  M Alschibaja; F May; U Treiber; R Paul; R Hartung
Journal:  Urologe A       Date:  2005-05       Impact factor: 0.639

Review 9.  A review of combination therapy in patients with benign prostatic hyperplasia.

Authors:  Kevin T McVary
Journal:  Clin Ther       Date:  2007-03       Impact factor: 3.393

10.  Minimally invasive prostatic urethral lift: surgical technique and multinational experience.

Authors:  Thomas A McNicholas; Henry H Woo; Peter T Chin; Damien Bolton; Manuel Fernández Arjona; Karl-Dietrich Sievert; Martin Schoenthaler; Ulrich Wetterauer; Eric J E J Vrijhof; Steven Gange; Francesco Montorsi
Journal:  Eur Urol       Date:  2013-01-19       Impact factor: 20.096

View more
  4 in total

1.  Racial/Ethnic Differences in the Use of Primary Care Providers and Preventive Health Services at a Midwestern University.

Authors:  Elizabeth S Focella; Victoria A Shaffer; Erin A Dannecker; Mary J Clark; Laura H Schopp
Journal:  J Racial Ethn Health Disparities       Date:  2015-08-18

Review 2.  A Scoping Review of Economic Evaluations of Workplace Wellness Programs.

Authors:  Nilay Unsal; GracieLee Weaver; Jeremy Bray; Daniel Bibeau
Journal:  Public Health Rep       Date:  2021-02-04       Impact factor: 2.792

3.  Medical cost analysis of a school district worksite wellness program.

Authors:  Ray M Merrill; James D LeCheminant
Journal:  Prev Med Rep       Date:  2016-01-26

4.  Pharmaceutical use according to participation in worksite wellness screening and health campaigns.

Authors:  Ray M Merrill; Carson T Telford
Journal:  Prev Med Rep       Date:  2018-09-11
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.